Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Qianhe Ren,Qifan Li,Chenye Shao,Pengpeng Zhang,Zhuangzhuang Hu,Jun Li,Wei Wang,Yue Yu
DOI: https://doi.org/10.1186/s12885-023-11249-8
IF: 4.638
2023-09-24
BMC Cancer
Abstract:Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of early diagnosis and accurate prognostic prediction.
oncology
What problem does this paper attempt to address?